Location: Oslo, Norway
CIK: 0001475373 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 12, 2026
Total Value: $439M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 745,955 | $40.24M | 9.2% | $53.94 * | $48.48 | -2.0% | COM | 110122108 |
| MRK | MERCK & CO INC | 363,651 | $38.28M | 8.7% | $105.26 * | $80.39 | +16.0% | COM | 58933Y105 |
| MDT | MEDTRONIC PLC | 269,644 | $25.9M | 5.9% | $96.06 | $83.75 | +16.0% | SHS | G5960L103 |
| BDX | BECTON DICKINSON & CO | 132,376 | $25.69M | 5.9% | $194.07 * | $211.58 | -10.4% | COM | 075887109 |
| GILD | GILEAD SCIENCES INC | 176,414 | $21.65M | 4.9% | $122.74 | $75.45 | +60.2% | COM | 375558103 |
| INCY | INCYTE CORP | 218,783 | $21.61M | 4.9% | $98.77 * | $71.18 | +35.9% | COM | 45337C102 |
| PFE | PFIZER INC | 859,539 | $21.4M | 4.9% | $24.90 | $25.42 | -1.5% | COM | 717081103 |
| AMGN | AMGEN INC | 60,956 | $19.95M | 4.5% | $327.31 * | $285.08 | +10.8% | COM | 031162100 |
| BIIB | BIOGEN INC | 85,475 | $15.04M | 3.4% | $175.99 * | $164.21 | -0.5% | COM | 09062X103 |
| IONS | IONIS PHARMACEUTICALS INC | 184,977 | $14.63M | 3.3% | $79.11 * | $46.09 | +63.4% | COM | 462222100 |
| CVS | CVS HEALTH CORP | 177,599 | $14.09M | 3.2% | $79.36 | $65.57 | +20.0% | COM | 126650100 |
| CAH | CARDINAL HEALTH INC | 61,946 | $12.73M | 2.9% | $205.50 * | $64.47 | +191.2% | COM | 14149Y108 |
| TMO | THERMO FISHER SCIENTIFIC INC | 21,688 | $12.57M | 2.9% | $579.45 * | $439.21 | +28.7% | COM | 883556102 |
| BRKR | BRUKER CORP | 254,697 | $12M | 2.7% | $47.11 * | $51.49 | -18.0% | COM | 116794108 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 132,478 | $11.91M | 2.7% | $89.92 * | $107.10 | -11.7% | COM | 98956P102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 198,505 | $11.8M | 2.7% | $59.43 * | $72.29 | -24.7% | COM | 09061G101 |
| ELV | ELEVANCE HEALTH INC FORMERLY | 32,546 | $11.41M | 2.6% | $350.55 * | $351.09 | -4.1% | COM | 036752103 |
| CNC | CENTENE CORP DEL | 258,109 | $10.62M | 2.4% | $41.15 * | $53.34 | -29.8% | COM | 15135B101 |
| GEHC | GE HEALTHCARE TECHNOLOGIES I | 114,390 | $9.382M | 2.1% | $82.02 * | $76.25 | +2.2% | COMMON STOCK | 36266G107 |
| EW | EDWARDS LIFESCIENCES CORP | 96,402 | $8.218M | 1.9% | $85.25 * | $78.07 | +5.1% | COM | 28176E108 |
| AVTR | AVANTOR INC | 695,403 | $7.969M | 1.8% | $11.46 * | $13.13 | -6.3% | COM | 05352A100 |
| BIO | BIO RAD LABS INC | 23,750 | $7.196M | 1.6% | $302.99 * | $294.39 | +6.0% | CL A | 090572207 |
| LH | LABCORP HOLDINGS INC | 27,019 | $6.779M | 1.5% | $250.88 * | $248.69 | +6.6% | COM SHS | 504922105 |
| LNTH | LANTHEUS HLDGS INC | 93,823 | $6.244M | 1.4% | $66.55 * | $74.91 | -22.3% | COM | 516544103 |
| TNDM | TANDEM DIABETES CARE INC | 267,091 | $5.871M | 1.3% | $21.98 * | $24.77 | -27.1% | COM NEW | 875372203 |
| REGN | REGENERON PHARMACEUTICALS | 7,165 | $5.53M | 1.3% | $771.87 * | $678.68 | 0.0% | COM | 75886F107 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 115,000 | $5.353M | 1.2% | $46.55 * | $44.52 | 0.0% | COM | 22663K107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 252,062 | $5.296M | 1.2% | $21.01 * | $13.80 | +26.4% | COM | 87164F105 |
| DXCM | DEXCOM INC | 76,122 | $5.052M | 1.2% | $66.37 * | $78.65 | -17.8% | COM | 252131107 |
| HCA | HCA HEALTHCARE INC | 10,784 | $5.035M | 1.1% | $466.86 | $365.96 | +26.7% | COM | 40412C101 |
| KURA | KURA ONCOLOGY INC | 455,841 | $4.736M | 1.1% | $10.39 | $7.26 | +44.6% | COM | 50127T109 |
| PTCT | PTC THERAPEUTICS INC | 61,923 | $4.704M | 1.1% | $75.96 * | $46.46 | +56.4% | COM | 69366J200 |
| ASND | ASCENDIS PHARMA A/S | 16,305 | $3.477M | 0.8% | $213.24 | $168.80 | — | SPONSORED ADR | 04351P101 |
| CGON | CG ONCOLOGY INC | 52,039 | $2.161M | 0.5% | $41.52 | $41.38 | 0.0% | COM | 156944100 |
| OGN | ORGANON & CO | 300,000 | $2.151M | 0.5% | $7.17 * | $9.78 | -19.3% | COMMON STOCK | 68622V106 |
| CERT | CERTARA INC | 230,565 | $2.031M | 0.5% | $8.81 * | $10.94 | -5.8% | COM | 15687V109 |